HEADER TRANSPORT PROTEIN 11-JUN-14 4TQI TITLE HUMAN TRANSTHYRETIN (TTR) COMPLEXED WITH 3-(9H-FLUOREN-9- TITLE 2 YLIDENEAMINOOXY)PROPANOIC ACID IN A DUAL BINDING MODE COMPND MOL_ID: 1; COMPND 2 MOLECULE: TRANSTHYRETIN; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: ATTR,PREALBUMIN,TBPA SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 TISSUE: PLASMA KEYWDS PEG TTR CRYSTALLIZATION, FLOURENONE BASED AMYLOID ANTAGONIST AND KEYWDS 2 INHIBITOR, PREALBUMIN, DUAL BINDING MODE, HORMONE TRANSPORTER, KEYWDS 3 TRANSPORT PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR E.A.STURA,L.CICCONE,S.NENCETTI,A.ROSSELLO,E.ORLANDINI REVDAT 5 27-SEP-23 4TQI 1 REMARK REVDAT 4 22-NOV-17 4TQI 1 REMARK REVDAT 3 26-AUG-15 4TQI 1 JRNL REVDAT 2 12-AUG-15 4TQI 1 JRNL REVDAT 1 24-JUN-15 4TQI 0 JRNL AUTH L.CICCONE,S.NENCETTI,A.ROSSELLO,L.TEPSHI,E.A.STURA, JRNL AUTH 2 E.ORLANDINI JRNL TITL X-RAY CRYSTAL STRUCTURE AND ACTIVITY OF FLUORENYL-BASED JRNL TITL 2 COMPOUNDS AS TRANSTHYRETIN FIBRILLOGENESIS INHIBITORS. JRNL REF J ENZYME INHIB MED CHEM 1 2015 JRNL REFN ESSN 1475-6374 JRNL PMID 26235916 REMARK 2 REMARK 2 RESOLUTION. 1.25 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.8.4_1496) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.25 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 35.72 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 95.6 REMARK 3 NUMBER OF REFLECTIONS : 63673 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.174 REMARK 3 R VALUE (WORKING SET) : 0.173 REMARK 3 FREE R VALUE : 0.208 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 3181 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 35.7322 - 3.5506 0.96 2862 151 0.1720 0.2219 REMARK 3 2 3.5506 - 2.8186 0.99 2800 148 0.1412 0.1586 REMARK 3 3 2.8186 - 2.4624 0.99 2768 144 0.1470 0.1682 REMARK 3 4 2.4624 - 2.2373 0.98 2733 143 0.1344 0.1976 REMARK 3 5 2.2373 - 2.0770 0.98 2710 143 0.1244 0.1456 REMARK 3 6 2.0770 - 1.9545 0.98 2688 141 0.1322 0.1530 REMARK 3 7 1.9545 - 1.8566 0.97 2676 141 0.1331 0.1826 REMARK 3 8 1.8566 - 1.7758 0.97 2679 141 0.1292 0.1617 REMARK 3 9 1.7758 - 1.7075 0.97 2654 140 0.1322 0.1693 REMARK 3 10 1.7075 - 1.6485 0.96 2611 138 0.1367 0.1845 REMARK 3 11 1.6485 - 1.5970 0.96 2641 139 0.1407 0.1985 REMARK 3 12 1.5970 - 1.5514 0.96 2618 137 0.1899 0.2223 REMARK 3 13 1.5514 - 1.5105 0.96 2597 137 0.2193 0.2490 REMARK 3 14 1.5105 - 1.4737 0.95 2603 137 0.2155 0.2844 REMARK 3 15 1.4737 - 1.4402 0.95 2577 136 0.2205 0.2343 REMARK 3 16 1.4402 - 1.4095 0.95 2584 136 0.2493 0.3093 REMARK 3 17 1.4095 - 1.3813 0.95 2597 137 0.2775 0.3163 REMARK 3 18 1.3813 - 1.3552 0.94 2545 133 0.3061 0.3333 REMARK 3 19 1.3552 - 1.3310 0.94 2582 136 0.3320 0.3503 REMARK 3 20 1.3310 - 1.3085 0.94 2518 131 0.3502 0.3780 REMARK 3 21 1.3085 - 1.2874 0.93 2527 133 0.3793 0.3513 REMARK 3 22 1.2874 - 1.2676 0.93 2520 133 0.3724 0.3746 REMARK 3 23 1.2676 - 1.2489 0.88 2402 126 0.4096 0.4559 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.200 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 22.000 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.006 2258 REMARK 3 ANGLE : 1.060 3118 REMARK 3 CHIRALITY : 0.044 324 REMARK 3 PLANARITY : 0.006 410 REMARK 3 DIHEDRAL : 14.139 801 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4TQI COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 12-JUN-14. REMARK 100 THE DEPOSITION ID IS D_1000202083. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-NOV-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.5 - 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SOLEIL REMARK 200 BEAMLINE : PROXIMA 2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9801 REMARK 200 MONOCHROMATOR : CRYOGENICALLY COOLED CHANNEL CUT REMARK 200 SI[111] CRYSTAL MONOCHROMATOR REMARK 200 OPTICS : CONVEX PREFOCUSSING MIRROR AND A REMARK 200 KIRKPATRICK-BAEZ PAIR OF REMARK 200 FOCUSSING MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 63728 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.250 REMARK 200 RESOLUTION RANGE LOW (A) : 43.200 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.7 REMARK 200 DATA REDUNDANCY : 8.040 REMARK 200 R MERGE (I) : 0.15100 REMARK 200 R SYM (I) : 0.14000 REMARK 200 FOR THE DATA SET : 11.1100 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.25 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.32 REMARK 200 COMPLETENESS FOR SHELL (%) : 91.5 REMARK 200 DATA REDUNDANCY IN SHELL : 7.20 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.640 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: 3GS0 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.70 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.15 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN: TTR 10 MG/ML + LIGAND 0.66 REMARK 280 MILLI-M IN 0.1 M NACL, 0.05 M NA ACETATE, PH 5.5. PRECIPITANT: REMARK 280 70% (30% PEG-4K, 0.2 M IMIDAZOLE MALATE, PH 6.0) AND 30% (12% REMARK 280 MPEG-5K, 0.1 M SODIUM ACETATE, PH 5.5). CRYOPROTECTANT: 40% (25 % REMARK 280 DIETHYLENE GLYCOL, 12.5 % MPD, 37.5 % 2,3-BUTANEDIOL, 12.5 % 1, REMARK 280 4-DIOXANE), 10% PEG 10K, 0.1 M (MIXED SODIUM PROPIONATE, SODIUM REMARK 280 CACODYLATE, BIS-TRIS-PROPANE) (65% COMPONENT A PH 4; 35% B PH REMARK 280 9.5), PH 5.7, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 21.62500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 43.18500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 21.62500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 43.18500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 43.25000 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 86.37000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 CAP 6BD A 201 LIES ON A SPECIAL POSITION. REMARK 375 NAM 6BD A 201 LIES ON A SPECIAL POSITION. REMARK 375 CAF 6BD B 201 LIES ON A SPECIAL POSITION. REMARK 375 CAR 6BD B 201 LIES ON A SPECIAL POSITION. REMARK 375 CAA 6BD B 201 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 302 LIES ON A SPECIAL POSITION. REMARK 375 HOH B 335 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 1 REMARK 465 PRO A 2 REMARK 465 THR A 3 REMARK 465 GLY A 4 REMARK 465 THR A 5 REMARK 465 GLY A 6 REMARK 465 GLU A 7 REMARK 465 SER A 8 REMARK 465 LYS A 9 REMARK 465 LYS A 126 REMARK 465 GLU A 127 REMARK 465 GLY B 1 REMARK 465 PRO B 2 REMARK 465 THR B 3 REMARK 465 GLY B 4 REMARK 465 THR B 5 REMARK 465 GLY B 6 REMARK 465 GLU B 7 REMARK 465 SER B 8 REMARK 465 LYS B 9 REMARK 465 LYS B 126 REMARK 465 GLU B 127 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 6BD A 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 6BD B 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL B 202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL B 203 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4TQH RELATED DB: PDB REMARK 900 TRANSTHYRETIN (TTR) WITH SIMILAR FLUORENONE BASED INHIBITOR IN DUAL REMARK 900 BINDING MODE REMARK 900 RELATED ID: 4TQ8 RELATED DB: PDB REMARK 900 TRANSTHYRETIN (TTR) WITH SIMILAR FLUORENONE BASED INHIBITOR IN DUAL REMARK 900 BINDING MODE REMARK 900 RELATED ID: 3GS0 RELATED DB: PDB REMARK 900 TRANSTHYRETIN (TTR) WITH THE SAME FLUORENONE BASED INHIBITOR IN REMARK 900 FORWARD BINDING MODE REMARK 900 RELATED ID: 4TQP RELATED DB: PDB DBREF 4TQI A 1 127 UNP P02766 TTHY_HUMAN 21 147 DBREF 4TQI B 1 127 UNP P02766 TTHY_HUMAN 21 147 SEQRES 1 A 127 GLY PRO THR GLY THR GLY GLU SER LYS CYS PRO LEU MET SEQRES 2 A 127 VAL LYS VAL LEU ASP ALA VAL ARG GLY SER PRO ALA ILE SEQRES 3 A 127 ASN VAL ALA VAL HIS VAL PHE ARG LYS ALA ALA ASP ASP SEQRES 4 A 127 THR TRP GLU PRO PHE ALA SER GLY LYS THR SER GLU SER SEQRES 5 A 127 GLY GLU LEU HIS GLY LEU THR THR GLU GLU GLU PHE VAL SEQRES 6 A 127 GLU GLY ILE TYR LYS VAL GLU ILE ASP THR LYS SER TYR SEQRES 7 A 127 TRP LYS ALA LEU GLY ILE SER PRO PHE HIS GLU HIS ALA SEQRES 8 A 127 GLU VAL VAL PHE THR ALA ASN ASP SER GLY PRO ARG ARG SEQRES 9 A 127 TYR THR ILE ALA ALA LEU LEU SER PRO TYR SER TYR SER SEQRES 10 A 127 THR THR ALA VAL VAL THR ASN PRO LYS GLU SEQRES 1 B 127 GLY PRO THR GLY THR GLY GLU SER LYS CYS PRO LEU MET SEQRES 2 B 127 VAL LYS VAL LEU ASP ALA VAL ARG GLY SER PRO ALA ILE SEQRES 3 B 127 ASN VAL ALA VAL HIS VAL PHE ARG LYS ALA ALA ASP ASP SEQRES 4 B 127 THR TRP GLU PRO PHE ALA SER GLY LYS THR SER GLU SER SEQRES 5 B 127 GLY GLU LEU HIS GLY LEU THR THR GLU GLU GLU PHE VAL SEQRES 6 B 127 GLU GLY ILE TYR LYS VAL GLU ILE ASP THR LYS SER TYR SEQRES 7 B 127 TRP LYS ALA LEU GLY ILE SER PRO PHE HIS GLU HIS ALA SEQRES 8 B 127 GLU VAL VAL PHE THR ALA ASN ASP SER GLY PRO ARG ARG SEQRES 9 B 127 TYR THR ILE ALA ALA LEU LEU SER PRO TYR SER TYR SER SEQRES 10 B 127 THR THR ALA VAL VAL THR ASN PRO LYS GLU HET 6BD A 201 42 HET 6BD B 201 42 HET GOL B 202 6 HET GOL B 203 6 HETNAM 6BD (2S)-3-[(9H-FLUOREN-9-YLIDENEAMINO)OXY]-2- HETNAM 2 6BD METHYLPROPANOIC ACID HETNAM GOL GLYCEROL HETSYN 6BD (S)-3-(9H-FLUOREN-9-YLIDENEAMINOOXY)-2-METHYLPROPANOIC HETSYN 2 6BD ACID HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 6BD 2(C17 H15 N O3) FORMUL 5 GOL 2(C3 H8 O3) FORMUL 7 HOH *265(H2 O) HELIX 1 AA1 ASP A 74 LEU A 82 1 9 HELIX 2 AA2 ASP B 74 LEU B 82 1 9 SHEET 1 AA1 8 SER A 23 PRO A 24 0 SHEET 2 AA1 8 LEU A 12 ASP A 18 -1 N ASP A 18 O SER A 23 SHEET 3 AA1 8 ARG A 104 SER A 112 1 O ILE A 107 N MET A 13 SHEET 4 AA1 8 SER A 115 THR A 123 -1 O THR A 119 N ALA A 108 SHEET 5 AA1 8 SER B 115 THR B 123 -1 O THR B 118 N TYR A 116 SHEET 6 AA1 8 ARG B 104 SER B 112 -1 N ALA B 108 O THR B 119 SHEET 7 AA1 8 LEU B 12 ASP B 18 1 N LEU B 17 O LEU B 111 SHEET 8 AA1 8 SER B 23 PRO B 24 -1 O SER B 23 N ASP B 18 SHEET 1 AA2 8 GLU A 54 LEU A 55 0 SHEET 2 AA2 8 LEU A 12 ASP A 18 -1 N VAL A 14 O LEU A 55 SHEET 3 AA2 8 ARG A 104 SER A 112 1 O ILE A 107 N MET A 13 SHEET 4 AA2 8 SER A 115 THR A 123 -1 O THR A 119 N ALA A 108 SHEET 5 AA2 8 SER B 115 THR B 123 -1 O THR B 118 N TYR A 116 SHEET 6 AA2 8 ARG B 104 SER B 112 -1 N ALA B 108 O THR B 119 SHEET 7 AA2 8 LEU B 12 ASP B 18 1 N LEU B 17 O LEU B 111 SHEET 8 AA2 8 GLU B 54 LEU B 55 -1 O LEU B 55 N VAL B 14 SHEET 1 AA3 8 TRP A 41 LYS A 48 0 SHEET 2 AA3 8 ALA A 29 LYS A 35 -1 N VAL A 32 O ALA A 45 SHEET 3 AA3 8 GLY A 67 ILE A 73 -1 O GLU A 72 N HIS A 31 SHEET 4 AA3 8 ALA A 91 ALA A 97 -1 O ALA A 91 N ILE A 73 SHEET 5 AA3 8 HIS B 88 ALA B 97 -1 O GLU B 89 N VAL A 94 SHEET 6 AA3 8 GLY B 67 ILE B 73 -1 N ILE B 73 O ALA B 91 SHEET 7 AA3 8 ALA B 29 LYS B 35 -1 N HIS B 31 O GLU B 72 SHEET 8 AA3 8 TRP B 41 LYS B 48 -1 O ALA B 45 N VAL B 32 SITE 1 AC1 10 LYS A 15 LEU A 17 THR A 106 ALA A 108 SITE 2 AC1 10 LEU A 110 SER A 117 THR A 119 VAL A 121 SITE 3 AC1 10 HOH A 302 HOH A 394 SITE 1 AC2 11 MET B 13 LYS B 15 LEU B 17 ALA B 108 SITE 2 AC2 11 ALA B 109 LEU B 110 SER B 117 THR B 119 SITE 3 AC2 11 VAL B 121 HOH B 414 HOH B 432 SITE 1 AC3 7 PRO A 86 PHE A 87 TYR A 114 THR B 96 SITE 2 AC3 7 ASN B 98 TYR B 105 HOH B 434 SITE 1 AC4 6 TRP A 41 LYS A 70 LYS B 70 GLU B 72 SITE 2 AC4 6 HIS B 90 GLU B 92 CRYST1 43.250 86.370 63.340 90.00 90.00 90.00 P 21 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023121 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011578 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015788 0.00000